PAROXYSMAL ATRIAL FIBRILLATION (PAF)
Clinical trials for PAROXYSMAL ATRIAL FIBRILLATION (PAF) explained in plain language.
Never miss a new study
Get alerted when new PAROXYSMAL ATRIAL FIBRILLATION (PAF) trials appear
Sign up with your email to follow new studies for PAROXYSMAL ATRIAL FIBRILLATION (PAF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart mapping tech could improve AFib treatment safety
Disease control Recruiting nowThis study tests a new mapping catheter and software to help doctors treat atrial fibrillation, a common heart rhythm problem. About 200 Chinese patients will receive a standard ablation procedure, but doctors will use the new tools to guide them. The goal is to see if the new de…
Matched conditions: PAROXYSMAL ATRIAL FIBRILLATION (PAF)
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
New heart zapping device could free patients from irregular heartbeat
Disease control Recruiting nowThis study tests a new device called FARAFLEX that uses electrical pulses to treat atrial fibrillation (AF), a condition where the heart beats irregularly. About 571 adults with AF that hasn't improved with medication will get this procedure. The goal is to see if it safely resto…
Matched conditions: PAROXYSMAL ATRIAL FIBRILLATION (PAF)
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New device aims to tame stubborn atrial fibrillation after first ablation fails
Disease control Recruiting nowThis study tests a new catheter system (Sphere-9) for a repeat heart ablation procedure in 400 people whose atrial fibrillation came back after an earlier ablation. The procedure uses radiofrequency and pulsed field energy to correct faulty heart signals. Participants will be fol…
Matched conditions: PAROXYSMAL ATRIAL FIBRILLATION (PAF)
Phase: NA • Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC